ArticleTransgenic research2019
Regulatory aspects of gene editing in Argentina.
Article in Transgenic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- CRISPR/Cas-based genome editing for enhancing grain quality traits in rice (Plant signaling & behavior · 2026Review
- From lab to market: industrialization barriers and regulation optimization for new breeding technologies in China.GM crops & food · 2026Article
- The Enhancement of Fungal Disease Resistance in Major Staple Crops Using CRISPR-Cas Technology.Genes · 2025Review
- CRISPR-Cas Gene Editing Technology in Potato.International journal of molecular sciences · 2025Review
- Latin America: a hub for agrobiotechnological innovations.Annals of botany · 2025Review
- Regulation of genome edited organisms in Australia.Transgenic research · 2024Article
- Genetic engineering and genome editing technologies as catalyst for Africa's food security: the case of plant biotechnology in Nigeria.Frontiers in genome editing · 2024Review
- Processes for regulating genetically modified and gene edited plants.GM crops & food · 2023Review
- From Transgenesis to Genome Editing in Crop Improvement: Applications, Marketing, and Legal Issues.International journal of molecular sciences · 2023Review
- GMOs or non-GMOs? The CRISPR Conundrum.Frontiers in plant science · 2023Review
- Multi-allelic gene editing in an apomictic, tetraploid turf and forage grass (Frontiers in plant science · 2023Article
- Managers' attitudes toward gene-editing technology and companies' R&D investment in gene-editing: the case of Chinese seed companies.GM crops & food · 2022Article
- Public perception of plant gene technologies worldwide in the light of food security.GM crops & food · 2022Article
- Enhancing Animal Disease Resistance, Production Efficiency, and Welfare through Precise Genome Editing.International journal of molecular sciences · 2022Review
- Enabling Genome Editing for Enhanced Agricultural Sustainability.Frontiers in genome editing · 2022Article
- Regulatory frameworks can facilitate or hinder the potential for genome editing to contribute to sustainable agricultural development.Frontiers in bioengineering and biotechnology · 2022Article
- CRISPR for accelerating genetic gains in under-utilized crops of the drylands: Progress and prospects.Frontiers in genetics · 2022Review
- Genome Editing for Sustainable Agriculture in Africa.Frontiers in genome editing · 2022Review
- Regulatory approaches for genome edited agricultural plants in select countries and jurisdictions around the world.Transgenic research · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Argentina is a world leader in regards to regulation and adoption of genetically modified (GM) crops. As a consequence, the regulatory aspects of gene editing applied to agriculture were considered proactively by the Argentinian regulators, who implemented simple but solid pioneering regulatory criteria for gene edited crops. At present, the Argentine regulatory system is fully able to establish if a gene-edited crop should be classified (and handled) either as a GM crop or a conventional new variety. To this end, the concept of "novel combination of genetic material" derived from the Cartagena Protocol on Biosafety is of decisive importance. After some pilot cases that have been managed under this criteria, now applicants appreciate the ease, speed and predictability of the regulation. Moreover, it has been considered by other countries in the course of developing their own regulations, thus acting also as a harmonization factor for the safe and effective insertion of these technologies in the global market.
Indexed as
Identifiers
31321697What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.